
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

39289456
72961
10.1038/s41598-024-72961-4
Article
Exploring the relationship between live microbe intake and obesity prevalence in adults
Chen Yuting
Ni Haixiang
Zhang Hong rosyzhang1229@126.com

https://ror.org/04epb4p87 grid.268505.c 0000 0000 8744 8924 Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhejiang Chinese Medical University, No.54, Youdian Road, Shangcheng District, Hangzhou, 310009 Zhejiang China
17 9 2024
17 9 2024
2024
14 2172419 4 2024
12 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Obesity has become a global health problem. In recent years, the influence of dietary microbes in the obese population has attracted the attention of scholars. Our study aimed to investigate the link between live microbe intake and obesity in adults. Participants (aged over 20 years) for this study were from the 1999–2018 National Health and Nutrition Examination Survey (NHANES). Participants were categorised into low, medium and high dietary live microbe intake groups. Linear regression was used to analyse the link between live microbe intake and body mass index (BMI) and waist circumference (WC). Logistic regression was used to analyse the link between live microbe intake and obesity and abdominal obesity prevalence. Restricted cubic spline curves (RCS) were used to check whether there was a non-linear relationship between live microbe intake and obesity. A total of 42,749 participants were included in this study and the number of obese reached 15,463. We found that live microbe intake was negatively linked to BMI and WC. In models adjusted for all confounders, the high live microbe intake group had lower obesity (OR = 0.812, 95%CI: 0.754–0.873) and abdominal obesity prevalence (OR = 0.851, 95%CI: 0.785–0.923) than the lowest intake group. Upon further quantification of live microbe intake, we found similar results. RCS analyses showed that live microbe intake was nonlinearly negatively correlated with BMI, WC, obesity, and abdominal obesity prevalence (P for non-linearity < 0.05). This study preliminarily reveals a negative link between live microbe intake and obesity in adults.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-024-72961-4.

Keywords

NHANES
Dietary live microbe
MedHi
Obesity
Abdominal obesity
Subject terms

Endocrinology
Endocrine system and metabolic diseases
Obesity
the Traditional Chinese Medicine Science and Technology Plan of Zhejiang2022ZB102 the National Natural Science Foundation of China82304940 issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

Today, obesity has become a global health challenge, affecting people’s quality of life1. Large population-based studies show that more than 200 million adults worldwide suffer from overweight2. The prevalence of obesity has doubled in more than 70 countries since 19803. Obesity is one of the major risk factors for a wide range of diseases, including cardiovascular disease (CVD), dyslipidemia, and cancers4–6. When exploring the factors contributing to the prevalence of obesity, attention is usually focused on dietary habits, lifestyle and genes7. In recent years, the link between obesity and microbial communities has been more thoroughly investigated by the scientific community8. The microbial communities in the body, especially the gut flora, are thought to play an essential part in the regulation of energy metabolism, nutrient absorption, and immune function9. Therefore, attention has been focused on the potential link between dietary intake of live microorganisms and obesity.

The microbial community in our body is the sum of the tiny organisms that inhabit our digestive system, skin, and other parts of the body, and the gut microbiota is one of the most widely studied categories10. The gut microbiota includes a wide variety of bacteria, fungi, and viruses, which are diverse and numerous11. In obesity research, scientists have found that the gut microbiota of obese individuals differs from that of normal-weight individuals12. Obese people’s gut microbiota is often less diverse and has a more particular bacterial composition13. These microbial changes may affect energy metabolism, appetite regulation, and weight control of the host14. The structure of the gut microbiota can be improved by dietary modification, especially by increasing the number of foods rich in live microorganisms, which can help reduce the risk of obesity15. As the understanding of the link between microbial communities and health continues to improve, a growing number of studies have started to draw attention to the link between the intake of live microorganisms and obesity8. Epidemiological studies have found that some foods rich in active probiotics or prebiotics, such as yoghurt, fermented foods, and high-fibre foods, are linked to a lower prevalence of obesity8. These foods not only improve the structure of the intestinal microbiota, but may also have a positive effect on reducing obesity by modulating energy metabolism and appetite regulation pathways16.

Dietary live microorganisms are defined as those microorganisms that continue to survive and exert beneficial effects in the human gastrointestinal tract, including probiotics and other beneficial microorganisms17. There has been a large body of research that demonstrates that probiotics may improve host health through modulation of the intestinal flora, including obesity, chronic kidney disease, and digestive disorders18–20. Previous research has focused on the effects of single probiotic supplements on adult obesity, with few studies finding a link between dietary intake of live bacteria and adult obesity. Therefore, we investigated the live microbe intake of U.S. adults who participated in the 1999–2018 National Health and Nutrition Examination Survey (NHANES), and explored the associations between live microbe intake and body mass index (BMI), waist circumference (WC), prevalence of obesity, and prevalence of abdominal obesity. By analysing the association between dietary live microbe intake and obesity, we can provide a scientific basis for the development of more scientific dietary recommendations and obesity prevention and control strategies.

Materials and methods

Study population

NHANES is an ongoing epidemiological survey conducted by the U.S. Centers for Disease Control and Prevention (NCHS). It describes the health and nutritional status of the U.S. population using a stratified, multistage probability cluster sampling methodology that provides important data for large population-based studies. These data include not only physiological measurements and health questionnaires, but also laboratory tests and nutritional surveys21. The NHANES study was approved by the NCHS Ethics Review Board and all participants provided informed consent.

In the 1999–2018 NHANES, we collected basic information on 101,316 participants. We excluded participants with missing dietary information assessing dietary living microbe (n = 11876), participants with missing data on BMI and WC (n = 10187), participants with age < 20 (n = 32532), participants who were pregnant (n = 1343), and participants with extreme energy intake at baseline (n = 2926). A total of 42,452 participants were used for analysis (Fig. S1).

Assessment of live microbe intake

First, 24-hour dietary recall data were collected from the 1999–2018 NHANES. Second, we linked dietary information to the United States Department of Agriculture (USDA) Food Survey Nutrition Database via food codes. According to previous literature, commercially aseptic or pasteurised storage-resistant processed foods contain very low levels of live microbes (< 104 CFU/g), raw, unpeeled fruits and vegetables contain moderate levels of live microbes ((104-107 CFU/g), and unprocessed fermented foods often contain high levels of live microbes (> 107 CFU/g)22–24. In addition, we combined the amount of food consumed by each person with a medium and high level of live microbes and defined it as MedHi. Depending on the microbial levels, we categorised participants into three groups: low intake (all foods consumed were low); moderate (any food consumed was moderate, not heavy); and high (any food consumed was high). In order to quantify the intake of live microorganisms, we classified participants into three groups according to MedHi intake: G1, consumers who did not consume any MedHi food; G2, MedHi food intake higher than 0 but lower than the median level of consumers; and G3, those with MedHi food intake higher than the average level of consumers. Table S1 shows the distribution of participants’ live microbe intake in 1999–2018 NHANES.

Assessment of obesity

Individuals’ height (m), weight (kg), and waist circumference (WC, cm) were measured by standardized protocols. Body mass index (BMI, kg/m2) was calculated by dividing weight (kg) by the square of height (m). Obesity was defined as BMI > 30 kg/m225. We defined abdominal obesity as WC > 102 cm for male and WC > 88 cm for female26.

Covariates

Information on age, sex, race, education level, and total energy intakes (kcal/day) was collected. According to the marital status of participants, they are divided into married/living with partner and single/divorced/widowed27. The poverty income ratio (PIR) was calculated by dividing household income by factors specific to household size28. Never smokers were classified as those who reported smoking < 100 cigarettes during their lifetime. Those who smoked > 100 cigarettes in their lifetime were considered as current smokers, and those who smoked > 100 cigarettes and had quit smoking were considered as former smokers29. Drinking status was classified as nondrinker, low-to-moderate drinker (< 2 drinks/day in men and < 1 drink/day in women), or heavy drinker (≥ 2 drinks/day in men and ≥ 1 drinks/day in women)29. Physical activity was divided into three groups: inactive, insufficiently active (moderate activity 1–5 times per week with metabolic equivalents [MET] 3–6 or vigorous activity 1–3 times per week with MET > 6), and active30. We obtained information on the prevalence of hypertension, diabetes, hyperlipidemia, cardiovascular disease (CVD) using self-reported questionnaires. All dietary supplements containing probiotics or specific microorganisms were classified as probiotic dietary supplements, and their intake was estimated by a dietary supplement questionnaire24.

Statistical analysis

All data analyses were data weighted in accordance with the NHANES analysis guidelines. Continuous variables without a normal distribution are presented as medians [interquartile ranges]. Categorical variables are presented as numbers (percentages). Continuous variables were compared using the Mann-Whitney U test, while categorical variables were compared using the chi-square test. Multiple interpolation of missing covariates using the mice package.

Linear regression analyses were used to assess the link of live microbe intake with BMI and WC in adults. Logistic regression analyses were used to assess the link of live microbe intake with obesity and abdominal obesity prevalence in adults. A restricted cubic spline curve (RCS) was used to examine whether there was a non-linear link between live microbe intake and obesity-related variables. To ensure the stability of the results, we also performed a stratified analysis according to covariates age (18–39, 40–59, or ≥ 60), sex (male or female), race/ethnicity (Non-Hispanic White, Non-Hispanic Black or Other), marital status (married/living with partner, or single/divorced/widowed), education level (below high school, high school, or above high school), family PIR (≤ 1.0, 1.1–3.0, or > 3.0), drinking status (nondrinker, former drinker, or current drinker), smoking status (never smoker, former smoker, or current smoker), physical activity (inactive, insufficiently active, or active), total energy intakes (in quartiles), hypertension (yes, or no), diabetes (yes, or no), hyperlipidemia (yes, or no), and self-reported CVD (yes, or no) when they were not the strata variables. In sensitivity analyses, we repeated regression analyses of live microbe intake and obesity-related outcomes after further adjustment of nonfood prebiotic and probiotic use. All analyses were performed using R (version 4.3.2) and P-values less than 0.05 were considered statistically significant.

Results

Baseline characteristics of the participants

Table 1 shows the basic characteristics of participants by obesity. We included a total of 42,749 participants and the number of obese reached 15,463. The mean BMI of the participants was 27.65 kg/m2, and the mean WC was 97 cm. Low, moderate, and high live microbe intake were found in 32.57%, 42.00%, and 25.42% of participants, respectively. Further quantifying live microbe intake, 32.57%, 32.94%, and 34.49% of adults in the G1, G2, and G3 groups, respectively. Obese participants were more likely to be middle-aged or older women, non-Hispanic black, not educated beyond tertiary level, of low economic level, infrequent smokers, infrequent drinkers, and physically inactive (P < 0.05). Obese participants were more likely to have hypertension, diabetes, hyperlipidemia, and CVD (P < 0.05). Obese participants had a lower proportion of people with high live microbe intake compared to non-obese participants (P < 0.05). Tables S2 and S3 shows the socio-demographic and health status characteristics of participants according to the low, medium and high dietary live microbe intake groups and the G1, G2 and G3 groups, respectively.

Table 1 Survey-weighted, sociodemographic and health status characteristics of the adult participants by category of obesity in NHANES 1999–2018.

Characteristics	Total (n = 42749)	Obesity	P value	
No (n = 26989)	Yes (n = 15463)	
Age (years)				< 0.001	
 20–39	13,647 (36.29)	9168 (38.58)	4479 (32.10)		
 40–59	14,044 (38.42)	8383 (36.65)	5661 (41.65)		
 ≥ 60	14,761 (25.29)	9438 (24.77)	5323 (26.25)		
Sex (%)				< 0.001	
 Female	21,834 (52.30)	13,111 (51.15)	8723 (54.39)		
 Male	20,618 (47.70)	13,878 (48.85)	6740 (45.61)		
Race/ethnicity (%)				< 0.001	
 Non-Hispanic White	19,146 (69.42)	12,661 (70.70)	6485 (67.09)		
 Non-Hispanic Black	8673 (10.56)	4692 (8.76)	3981 (13.86)		
 Other race	14,633 (20.02)	9636 (20.54)	4997 (19.05)		
Marital status (%)				0.480	
 Married/living with partner	16,658 (35.42)	10,526 (35.59)	6132 (35.10)		
 Single/divorced/widowed	25,794 (64.58)	16,463 (64.41)	9331 (64.90)		
Education level (%)				< 0.001	
 Below high school	11,102 (16.48)	6946 (16.13)	4156 (17.11)		
 High school	9844 (23.98)	6026 (22.80)	3818 (26.14)		
 Above high school	21,506 (59.54)	14,017 (61.07)	7489 (56.75)		
Family PIR (%)				< 0.001	
 ≤ 1.0	8512 (13.68)	5251 (13.29)	3261 (14.38)		
 1.1–3.0	17,762 (35.72)	11,009 (34.34)	6753 (38.24)		
 > 3.0	16,178 (50.60)	10,729 (52.36)	5449 (47.38)		
Smoking status (%)				< 0.001	
 Never smoker	23,020 (53.97)	14,503 (53.85)	8517 (54.19)		
 Former smoker	10,712 (25.08)	6553 (23.82)	4159 (27.40)		
 Current smoker	8720 (20.95)	5933 (22.33)	2787 (18.41)		
Drinking status (%)				< 0.001	
 Nondrinker	9663 (18.45)	5833 (17.46)	3830 (20.25)		
 Low-to-moderate drinker	29,422 (72.19)	18,709 (71.73)	10,713 (73.03)		
 Heavy drinker	3367 (9.36)	2447 (10.81)	920 (6.71)		
Physical activity (%)				< 0.001	
 Inactive	11,260 (21.40)	6648 (19.05)	4612 (25.71)		
 Insufficiently active	16,005 (40.69)	10,205 (40.91)	5800 (40.28)		
 Active	15,187 (37.91)	10,136 (40.04)	5051 (34.01)		
 Total energy intakes (kcal/day)	1981.0 (1492.0, 2586.0)	1984.0 (1493.0, 2586.0)	1979.0 (1488.0, 2584.0)	0.441	
Hypertension (%)				< 0.001	
 No	24,329 (63.06)	17,205 (70.04)	7124 (50.27)		
 Yes	18,123 (36.94)	9784 (29.96)	8339 (49.73)		
Diabetes (%)				< 0.001	
 No	35,093 (87.29)	23,696 (92.13)	11,397 (78.44)		
 Yes	7359 (12.71)	3293 (7.87)	4066 (21.56)		
Hyperlipidemia (%)				< 0.001	
 No	12,530 (30.38)	9290 (35.84)	3240 (20.39)		
 Yes	29,922 (69.62)	17,699 (64.16)	12,223 (79.61)		
Self-reported CVD (%)				< 0.001	
 No	37,832 (91.65)	24,370 (92.91)	13,462 (89.34)		
 Yes	4620 (8.35)	2619 (7.09)	2001 (10.66)		
MedHi	56.70 (0.00, 182.79)	66.00 (0.00, 197.31)	42.00 (0.00, 162.75)	< 0.001	
Category of MedHia				< 0.001	
 Low	15,039 (32.57)	9178 (30.75)	5861 (35.91)		
 Medium	18,458 (42.00)	11,906 (42.72)	6552 (40.70)		
 High	8955 (25.42)	5905 (26.53)	3050 (23.39)		
Category of MedHib				< 0.001	
 G1	15,039 (32.57)	9178 (30.75)	5861 (35.91)		
 G2	13,707 (32.94)	8713 (32.68)	4994 (33.41)		
 G3	13,706 (34.49)	9098 (36.57)	4608 (30.67)		
Body mass index (kg/m2)	27.65 (24.04, 32.11)	25.12 (22.61, 27.41)	34.07 (31.80, 38.00)	< 0.001	
Waist circumference (cm)	97.00 (86.50, 108.20)	90.00 (82.00, 97.20)	112.30 (105.40, 120.90)	< 0.001	
PIR poverty income ratio, CVD cardiovascular disease. Continuous variables without a normal distribution are presented as medians [interquartile ranges]. Categorical variables are presented as numbers (percentages). Sampling weights were applied for calculation of demographic descriptive statistics; N reflect the study sample while percentages reflect the survey-weighted data.

aParticipants were also classified into three different groups considering the general intake of foods with varying contents of microbe: low (all foods consumed were Low); moderate (any foods consumed were Medium but not High); and high (any foods consumed were High).

bParticipants were categorized into three groups based on the MedHi consumption to quantify the ingestion of live microbes: G1, consumers without intakes of any MedHi food; G2, those with intakes of MedHi food above zero but below the median level for consumers; G3, those with intakes of MedHi food above the median level for consumers.

Associations between live microbe intake and BMI and WC

Firstly, we explored the link between live microbe intake and BMI and WC (Tables 2 and 3). Linear regression analysis showed that live microbe intake was negatively linked to BMI (β = -0.246, 95%CI: -0.300, 0.193) and WC (β = -0.576, 95%CI: -0.706, 0.447). The negative correlation between live microbe intake and BMI (β=-0.239, 95%CI: -0.293, 0.186) and WC (β=-0.641, 95%CI: -0.767, 0.515) persisted after adjusting for age, sex and race. In the model adjusted for all confounders, each 1% increase in live microbe intake was linked to a decrease in BMI (β=-0.202, 95%CI: -0.253, 0.150) and WC (β=-0.497, 95%CI: -0.617, 0.377), respectively. RCS analyses showed a non-linear and negative correlation between live microbe intake and BMI and WC, with inflection points of 177.16 and 177.19 (P for non-linearity < 0.05) (Fig. 1A, B).

Table 2 Linear regression analysis of dietary live microbe intake with BMI among adults in NHANES 1999–2018.

	Crude	Model 1	Model 2	
β (95% CI)	P value	β (95% CI)	P value	β (95% CI)	P value	
Per 100 unit increase	− 0.246 (− 0.300, − 0.193)	< 0.001	− 0.239 (− 0.293, − 0.186)	< 0.001	− 0.202 (− 0.253, − 0.150)	< 0.001	
Category of MedHia	
 Low	00 [Reference]		0 [Reference]		0 [Reference]		
 Medium	− 0.631 (− 0.826, − 0.436)	< 0.001	− 0.6 (− 0.795, − 0.405)	< 0.001	− 0.572 (− 0.756, − 0.388)	< 0.001	
 High	− 0.858 (− 1.076, − 0.641)	< 0.001	− 0.725 (− 0.942, − 0.509)	< 0.001	− 0.527 (− 0.732, − 0.323)	< 0.001	
 P for trend		< 0.001		< 0.001		< 0.001	
Category of MedHi†	
 G1	0 [Reference]		0 [Reference]		0 [Reference]		
 G2	− 0.433 (− 0.631, − 0.235)	< 0.001	− 0.352 (− 0.551, − 0.153)	< 0.001	− 0.328 (− 0.517, − 0.138)	< 0.001	
 G3	− 0.987 (− 1.203, − 0.772)	< 0.001	− 0.936 (− 1.150, − 0.722)	< 0.001	− 0.804 (− 1.006, − 0.602)	< 0.001	
 P for trend		< 0.001		< 0.001		< 0.001	
Model 1 was adjusted for age (18–39, 40–59, or ≥ 60), sex (male or female), and race/ethnicity (Non-Hispanic White, Non-Hispanic Black or Other); Model 2 was adjusted as model 1 plus marital status (married/living with partner, or single/divorced/widowed), education level (below high school, high school, or above high school), family PIR (≤ 1.0, 1.1–3.0, or > 3.0), drinking status (nondrinker, former drinker, or current drinker), smoking status (never smoker, former smoker, or current smoker), physical activity (inactive, insufficiently active, or active), total energy intakes (in quartiles), hypertension (yes, or no), diabetes (yes, or no), hyperlipidemia (yes, or no), and self-reported CVD (yes, or no).

aParticipants were also classified into three different groups considering the general intake of foods with varying contents of microbe: low (all foods consumed were Low); moderate (any foods consumed were Medium but not High); and high (any foods consumed were High).

bParticipants were categorized into three groups based on the MedHi consumption of quantify the ingestion of live microbes: G1, consumers without intakes of any MedHi food; G2, those with intakes of MedHi food above zero but below the median level for consumers; G3, those with intakes of MedHi food above the median level for consumers.

Table 3 Linear regression analysis of dietary live microbe intake with waist circumference among adults in NHANES 1999–2018.

	Crude	Model 1	Model 2	
β (95% CI)	P value	β (95% CI)	P value	β (95% CI)	P value	
Per 100 unit increase	− 0.576 (− 0.706, − 0.447)	< 0.001	− 0.641 (− 0.767, − 0.515)	< 0.001	− 0.497 (− 0.617, − 0.377)	< 0.001	
Category of MedHia	
 Low	0 [Reference]		0 [Reference]		00 [Reference]		
 Medium	− 1.549 (− 2.038, − 1.060)	< 0.001	− 1.717 (− 2.174, − 1.260)	< 0.001	− 1.507 (− 1.940, − 1.074)	< 0.001	
 High	− 2.247 (− 2.819, − 1.676)	< 0.001	− 2.003 (− 2.540, − 1.467)	< 0.001	− 1.313 (− 1.809, − 0.816)	< 0.001	
 P for trend		< 0.001		< 0.001		< 0.001	
Category of MedHib	
 G1	0 [Reference]		0 [Reference]		0 [Reference]		
 G2	− 1.206 (− 1.712, − 0.700)	< 0.001	− 1.049 (− 1.510, − 0.588)	< 0.001	− 0.887 (− 1.322, − 0.453)	< 0.001	
 G3	− 2.391 (− 2.925, − 1.858)	< 0.001	− 2.586 (− 3.095, − 2.077)	< 0.001	− 2.036 (− 2.511, − 1.561)	< 0.001	
 P for trend		< 0.001		< 0.001		< 0.001	
Model 1 was adjusted for age (18–39, 40–59, or ≥ 60), sex (male or female), and race/ethnicity (Non-Hispanic White, Non-Hispanic Black or Other); Model 2 was adjusted as model 1 plus marital status (married/living with partner, or single/divorced/widowed), education level (below high school, high school, or above high school), family PIR (≤ 1.0, 1.1–3.0, or > 3.0), drinking status (nondrinker, former drinker, or current drinker), smoking status (never smoker, former smoker, or current smoker), physical activity (inactive, insufficiently active, or active), total energy intakes (in quartiles), hypertension (yes, or no), diabetes (yes, or no), hyperlipidemia (yes, or no), and self-reported CVD (yes, or no).

aParticipants were also classified into three different groups considering the general intake of foods with varying contents of microbe: low (all foods consumed were Low); moderate (any foods consumed were Medium but not High); and high (any foods consumed were High).

bParticipants were categorized into three groups based on the MedHi consumption of quantify the ingestion of live microbes: G1, consumers without intakes of any MedHi food; G2, those with intakes of MedHi food above zero but below the median level for consumers; G3, those with intakes of MedHi food above the median level for consumers.

Fig. 1 The exposure-response association of live microbe intake with BMI (A), WC (B), obesity (C) and abdominal obesity prevalence (D) among adults in NHANES 1999–2018 by restricted cubic spline (RCS). Analyses were adjusted for covariates age (18–39, 40–59, or ≥ 60), sex (male or female), race/ethnicity (Non-Hispanic White, Non-Hispanic Black or Other), marital status (married/living with partner, or single/divorced/widowed), education level (below high school, high school, or above high school), family PIR (≤ 1.0, 1.1–3.0, or > 3.0), drinking status (nondrinker, former drinker, or current drinker), smoking status (never smoker, former smoker, or current smoker), physical activity (inactive, insufficiently active, or active), total energy intakes (in quartiles), hypertension (yes, or no), diabetes (yes, or no), hyperlipidemia (yes, or no), and self-reported CVD (yes, or no) when they were not the strata variables.

Associations between live microbe intake and obesity and abdominal obesity prevalence

We explored the link between live microbe intake and obesity and abdominal obesity prevalence (Tables 4 and 5). Logistic regression analyses showed that obesity (OR = 0.755, 95%CI: 0.707–0.806) and abdominal obesity prevalence (OR = 0.880, 95%CI: 0.820–0.945) were significantly lower in the high dietary intake group compared with the low dietary intake group. After adjusting for age, sex, and race, obesity and abdominal obesity prevalence were 22.5% (OR = 0.775, 95%CI: 0.724–0.829) and 21.3% (OR = 0.787, 95%CI: 0.729–0.850) lower in the high live microbe intake group. In models adjusted for all confounders, the high live microbe intake group had lower obesity (OR = 0.812, 95%CI: 0.754–0.873) and abdominal obesity prevalence (OR = 0.851, 95%CI: 0.785–0.923) than the lowest intake group. After further quantifying dietary live microbe intake, we found that obesity and abdominal obesity prevalence were 26.3% (OR = 0.737, 95%CI: 0.683–0.796) and 23.2% lower in the G3 group compared to the G1 group (OR = 0.758, 95%CI: 0.712–0.829). RCS analyses showed that live microbe intake was negatively and non-linearly linked to obesity and abdominal obesity prevalence, with inflection points of 173.35 and 170.84 (P for non-linearity < 0.05) (Fig. 1C, D).

Table 4 Logistic regression analysis of dietary live microbe intake with the prevalence of obesity among adults in NHANES 1999–2018.

	Crude	Model 1	Model 2	
OR (95% CI)	P value	OR (95% CI)	P value	OR (95% CI)	P value	
Per 100 unit increase	0.916 (0.897, 0.935)	< 0.001	0.916 (0.897, 0.936)	< 0.001	0.922 (0.901, 0.943)	< 0.001	
Category of MedHia	
 Low	1 [Reference]		1 [Reference]		1 [Reference]		
 Medium	0.816 (0.769, 0.865)	< 0.001	0.818 (0.769, 0.869)	< 0.001	0.817 (0.766, 0.872)	< 0.001	
 High	0.755 (0.707, 0.806)	< 0.001	0.775 (0.724, 0.829)	< 0.001	0.812 (0.754, 0.873)	< 0.001	
 P for trend		< 0.001		< 0.001		< 0.001	
Category of MedHib	
 G1	1 [Reference]		1 [Reference]		1 [Reference]		
 G2	0.876 (0.826, 0.928)	< 0.001	0.889 (0.837, 0.944)	< 0.001	0.892 (0.836, 0.952)	< 0.001	
 G3	0.718 (0.669, 0.770)	< 0.001	0.722 (0.672, 0.776)	< 0.001	0.737 (0.683, 0.796)	< 0.001	
 P for trend		< 0.001		< 0.001		< 0.001	
Model 1 was adjusted for age (18–39, 40–59, or ≥ 60), sex (male or female), and race/ethnicity (Non-Hispanic White, Non-Hispanic Black or Other); Model 2 was adjusted as model 1 plus marital status (married/living with partner, or single/divorced/widowed), education level (below high school, high school, or above high school), family PIR (≤ 1.0, 1.1–3.0, or > 3.0), drinking status (nondrinker, former drinker, or current drinker), smoking status (never smoker, former smoker, or current smoker), physical activity (inactive, insufficiently active, or active), total energy intakes (in quartiles), hypertension (yes, or no), diabetes (yes, or no), hyperlipidemia (yes, or no), and self-reported CVD (yes, or no).

aParticipants were also classified into three different groups considering the general intake of foods with varying contents of microbe: low (all foods consumed were Low); moderate (any foods consumed were Medium but not High); and high (any foods consumed were High).

bParticipants were categorized into three groups based on the MedHi consumption of quantify the ingestion of live microbes: G1, consumers without intakes of any MedHi food; G2, those with intakes of MedHi food above zero but below the median level for consumers; G3, those with intakes of MedHi food above the median level for consumers.

Table 5 Logistic regression analysis of dietary live microbe intake with the prevalence of abdominal obesity among adults in NHANES 1999–2018.

	Crude	Model 1	Model 2	
OR (95% CI)	P value	OR (95% CI)	P value	OR (95% CI)	P value	
Per 100 unit increase	0.951 (0.935, 0.967)	< 0.001	0.923 (0.906, 0.939)	< 0.001	0.935 (0.918, 0.953)	< 0.001	
Category of MedHia	
 Low	1 [Reference]		1 [Reference]		1 [Reference]		
 Medium	0.937 (0.884, 0.995)	0.033	0.832 (0.781, 0.885)	< 0.001	0.844 (0.789, 0.903)	< 0.001	
 High	0.880 (0.820, 0.945)	< 0.001	0.787 (0.729, 0.850)	< 0.001	0.851 (0.785, 0.923)	< 0.001	
 P for trend		< 0.001		< 0.001		< 0.001	
Category of MedHib	
 G1	1 [Reference]		1 [Reference]		1 [Reference]		
 G2	0.981 (0.924, 1.042)	0.526	0.909 (0.854, 0.968)	0.003	0.926 (0.867, 0.990)	0.024	
 G3	0.857 (0.803, 0.916)	< 0.001	0.731 (0.681, 0.786)	< 0.001	0.768 (0.712, 0.829)	< 0.001	
 P for trend		< 0.001		< 0.001		< 0.001	
Model 1 was adjusted for age (18–39, 40–59, or ≥ 60), sex (male or female), and race/ethnicity (Non-Hispanic White, Non-Hispanic Black or Other); Model 2 was adjusted as model 1 plus marital status (married/living with partner, or single/divorced/widowed), education level (below high school, high school, or above high school), family PIR (≤ 1.0, 1.1–3.0, or > 3.0), drinking status (nondrinker, former drinker, or current drinker), smoking status (never smoker, former smoker, or current smoker), physical activity (inactive, insufficiently active, or active), total energy intakes (in quartiles), hypertension (yes, or no), diabetes (yes, or no), hyperlipidemia (yes, or no), and self-reported CVD (yes, or no).

aParticipants were also classified into three different groups considering the general intake of foods with varying contents of microbe: low (all foods consumed were Low); moderate (any foods consumed were Medium but not High); and high (any foods consumed were High).

bParticipants were categorized into three groups based on the MedHi consumption of quantify the ingestion of live microbes: G1, consumers without intakes of any MedHi food; G2, those with intakes of MedHi food above zero but below the median level for consumers; G3, those with intakes of MedHi food above the median level for consumers.

Stratified analyses

To test the stability of the link between live microbe intake and obesity-related outcomes, we conducted subgroup analyses among age, sex, race, marital status, education level, family PIR, smoking status, drinking status, physical activity, hypertension, diabetes, hyperlipidemia, and self-reported CVD. In the study of MedHi per 100 unit increase and obesity prevalence, age, race, education level, physical activity, and diabetes mellitus had some effect on the correlation (Fig. 2A). The negative link between MedHi per 100 unit increase and obesity prevalence was more pronounced in participants who were young, non-Hispanic white, with higher education, physically active, and non-diabetic. In the study of MedHi per 100 unit increase and abdominal obesity prevalence, age, sex, education level, physical activity, hypertension, and diabetes mellitus had some effect on the correlation (Fig. 2B). The negative link between MedHi per 100 unit increase and abdominal obesity prevalence was more pronounced in participants who were young males, had higher education, were physically active, non-hypertensive, and non-diabetic. In addition, age, sex, race, education level, physical activity, diabetes, and self-reported CVD had some effect on the correlation in the study of MedHi per 100 unit increase with BMI and WC (Fig. S2A, B).

Fig. 2 Stratified analyses of the associations of live microbe intake with obesity (A) and abdominal obesity prevalence (B) among adults in NHANES 1999–2018. Analyses were adjusted for covariates age (18–39, 40–59, or ≥ 60), sex (male or female), race/ethnicity (Non-Hispanic White, Non-Hispanic Black or Other), marital status (married/living with partner, or single/divorced/widowed), education level (below high school, high school, or above high school), family PIR (≤ 1.0, 1.1–3.0, or > 3.0), drinking status (nondrinker, former drinker, or current drinker), smoking status (never smoker, former smoker, or current smoker), physical activity (inactive, insufficiently active, or active), total energy intakes (in quartiles), hypertension (yes, or no), diabetes (yes, or no), hyperlipidemia (yes, or no), and self-reported CVD (yes, or no) when they were not the strata variables.

Sensitivity analyses

In models further adjusted for non-food prebiotic and probiotic use, we found live microbe intake to be significantly and negatively linked to BMI (β = -0.206, 95%CI: -0.268, 0.144) and WC (β = -0.5, 95%CI: -0.648, 0.353) (Table S4). Using the low dietary live microbe intake group as the reference group, the high live microbe intake group was negatively linked to BMI (β=-0.616, 95%CI: -0.895, 0.337) and WC (β=-1.443, 95%CI: -2.119, 0.767). Using group G1 as the reference group, group G3 was negatively linked to BMI (β=-0.798, 95%CI: -1.066, 0.531) and WC (β=-2.008, 95%CI: -2.672, 1.344). Obesity (OR = 0.793, 95%CI: 0.715–0.878) and abdominal obesity prevalence (OR = 0.837, 95%CI: 0.747–0.939) were significantly lower in the high live microbe intake group compared to the low dietary live microbe intake group (Table S5). Participants in the G3 group had a 24.3% (OR = 0.757, 95%CI: 0.683–0.840) and 22.1% (OR = 0.779, 95%CI: 0.701–0.865) reduction in obesity and abdominal obesity prevalence compared to the G1 group. The results of the sensitivity analyses were similar to the results of our main analyses, suggesting that the stability of our study.

Discussion

We included a total of 42,749 participants, reaching 15,463 obese. The analyses showed a negative association between dietary live microbe intake and obesity-related outcomes. Specifically, obesity and abdominal obesity prevalence were lower in the high microbe intake group than in the lowest intake group. RCS analyses showed that live microbe intake was nonlinearly and negatively linked to obesity-related outcomes prevalence. Age, education level, and prevalence of diabetes may had some effect on the correlation between microbe intake and obesity-related outcomes.

Obesity has become a global issue as living standards have improved and eating patterns have changed. Previous research suggests that the global prevalence of obesity will be 18% in men and 21% in women by 202531. Obesity is not just a personal health issue, but also a significant risk factor for numerous chronic conditions32. Therefore, the study of obesity and its related factors has become more important. Obesity is a complex multifactorial disease, and its pathogenesis involves genetic, environmental and lifestyle aspects33. The role of the microbial community has received increasing attention when exploring strategies for the prevention obesity34. Over the past few decades, studies have demonstrated a strong link between the microbial community (gut flora) in the body and obesity35. Increased intake of live microorganisms is linked with the diversity of the gut flora, which in turn is strongly linked to the development of obesity. Consumption of foods rich in live microorganisms, such as yoghurt, promotes the diversity of the gut flora and reduces obesity prevalence8.

A systematic review that pooled 15 studies showed that probiotic supplementation reduced body weight and treated obesity-related complications compared to a placebo group19. A study evaluating the anti-obesity effects of Lactobacillus gasseri BNR17 in humans found that daily intake of BNR17 helped to reduce the amount of visceral fat in obese adult36. Hadi et al. showed that after eight weeks of continuous supplementation with probiotic preparations in obese or overweight adults, their TG, TC, LDL-C, and body weight were significantly reduced37. Kadooka et al. found that after supplementation with fermented milk containing Lactobacillus gasseri SBT2055, obese subjects had a significant reduction in visceral fat, subcutaneous fat, and body weight38. Sharafedtinov et al. found that supplementation of cheese containing the probiotic Lactobacillus plantarum improved BMI in obese hypertensive patients39. Mohammadi-Sartang et al. concluded that consumption of fortified yoghurt for 10 consecutive weeks reduced WC and body fat percentage and increased insulin sensitivity in obese subjects40. Although most studies have demonstrated the potential value of probiotics in the treatment of obesity, further trials are needed to ensure their anti-obesity effects in the population. In addition, food delivery matrices of probiotic formulations are more advantageous compared to direct administration of extracted microorganisms41. Gomes et al. found that supplementation with a probiotic mixture reduced abdominal obesity in adult females compared to dietary interventions alone42. Similarly, our study showed that dietary live microbe intake was negatively correlated with BMI and WC. In addition, obesity and abdominal obesity prevalence were significantly lower in the high microbe intake population.

The mechanisms underlying the link between live microbe intake and obesity are not fully understood, but there are several possible explanations. First, the intake of abundant active microbes helps to maintain the balance of gut flora helping to control obesity43.Quigley and other scholars have suggested that certain probiotics can produce bacteriocins or antitoxins, which inhibit the growth of pro-inflammatory microbes while promoting the growth of beneficial strains of microbes44. Second, active microbes influence host energy absorption and utilisation by participating in the metabolism of nutrients in the gut45. Turnbaugh et al. showed that the microbiota of the obese group had a significantly increased ability to derive energy from the diet35. Third, active microbes may reduce the incidence of obesity by reducing inflammatory responses46. Finamore et al. showed that supplementation with food-borne microbes can inhibit obesity-associated inflammation and reduce blood lipid levels47. Fourth, active microbes may reduce the incidence of obesity by affecting insulin sensitivity48. Insulin is a key hormone for controlling blood glucose levels, and obesity is often accompanied by insulin resistance. Kang et al. found that Lactobacillus acidophilus treatment reduced insulin resistance in mice on a high-fat diet while improving glucose and lipid metabolism49.

This study has several strengths. First, the data used in this study are from NHANES, a large, population-representative study that is highly robust. Second, we used a variety of classification methods and the direction of all results remained consistent, indicating that our results are stable and reliable. Third, we analysed the effect of food-based intake of live microbes on obesity-related outcomes, rather than the use of a particular probiotic supplement. However, there are some limitations of this study. First, dietary data were collected using the 24-hour recall method, which does not reflect daily dietary intake and may be subject to recall bias. Second, the estimation method of dietary microbiological content was based on previous studies and expert opinions rather than direct testing, which lacked some accuracy. Third, this was a cross-sectional study and could not provide a causal association between live microbe intake and obesity-related outcomes. Finally, our study is the lack of data on medication use, which is known to influence the gut microbiome and could potentially confound the observed associations between live microbe intake and obesity. Future research should consider the impact of medication intake to provide a more comprehensive understanding of this relationship.

Conclusion

We found a non-linear negative correlation between live microbe intake and BMI, WC, obesity and abdominal obesity prevalence in adults. Increased intake of dietary live microbes can help improve obesity-related outcomes in the population.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Acknowledgements

We appreciate the people who contributed to the NHANES data we studied.

Author contributions

The authors’ responsibilities were as follows—HZ: designed the research, and had primary responsibility for the final content; YC: conducted analyses and wrote the first draft of the paper; HN: revised the manuscript; and all authors: read and approved the final manuscript and approved the final submitted version.

Funding

This work was supported by Funding: grants from the Traditional Chinese Medicine Science and Technology Plan of Zhejiang (2022ZB102 to HZ) and the National Natural Science Foundation of China (82304940 to HZ).

Data availability

NHANES data described in this manuscript are available at https://wwwn.cdc.gov/nchs/nhanes/.

Declarations

Competing interests

The authors declare no competing interests.

Ethics, consent and permissions

All participants provided written informed consent and study procedures were approved by the National Center for Health Statistics Research Ethics Review Board (Protocol Number: Protocol #98 -2, Protocol #2005-06, and Protocol #2011-17).

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Perdomo CM Cohen RV Sumithran P Clement K Fruhbeck G Contemporary medical, device, and surgical therapies for obesity in adults Lancet 2023 401 10382 1116 1130 10.1016/S0140-6736(22)02403-5 36774932
Perdomo, C. M., Cohen, R. V., Sumithran, P., Clement, K. & Fruhbeck, G. Contemporary medical, device, and surgical therapies for obesity in adults. Lancet. 401(10382), 1116–1130 (2023).36774932
2. Caballero B Humans against obesity: Who will win? Adv. Nutr. 2019 10 suppl_1 S4 S9 10.1093/advances/nmy055 30721956
Caballero, B. Humans against obesity: Who will win? Adv. Nutr. 10(suppl_1), S4–S9 (2019).30721956
3. Collaborators GBDO Health effects of overweight and obesity in 195 countries over 25 years N Engl. J. Med. 2017 377 1 13 27 10.1056/NEJMoa1614362 28604169
Collaborators, G. B. D. O. et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl. J. Med. 377(1), 13–27 (2017).28604169
4. Owei I Umekwe N Provo C Wan J Dagogo-Jack S Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: Role in prediction of incident pre-diabetes in a longitudinal biracial cohort BMJ Open. Diabetes Res. Care 2017 5 1 e000415 10.1136/bmjdrc-2017-000415 28878939
Owei, I., Umekwe, N., Provo, C., Wan, J. & Dagogo-Jack, S. Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: Role in prediction of incident pre-diabetes in a longitudinal biracial cohort. BMJ Open. Diabetes Res. Care. 5(1), e000415 (2017).28878939
5. Flegal KM Panagiotou OA Graubard BI Estimating population attributable fractions to quantify the health burden of obesity Ann. Epidemiol. 2015 25 3 201 207 10.1016/j.annepidem.2014.11.010 25511307
Flegal, K. M., Panagiotou, O. A. & Graubard, B. I. Estimating population attributable fractions to quantify the health burden of obesity. Ann. Epidemiol. 25(3), 201–207 (2015).25511307
6. Fruhbeck G Obesity: The gateway to ill health—An EASO position statement on a rising public health, clinical and scientific challenge in Europe Obes. Facts 2013 6 2 117 120 10.1159/000350627 23548858
Fruhbeck, G. et al. Obesity: The gateway to ill health—An EASO position statement on a rising public health, clinical and scientific challenge in Europe. Obes. Facts. 6(2), 117–120 (2013).23548858
7. Kim D Hou W Wang F Arcan C Factors affecting obesity and Waist Circumference among US adults Prev. Chronic Dis. 2019 16 E02 10.5888/pcd16.180220 30605422
Kim, D., Hou, W., Wang, F. & Arcan, C. Factors affecting obesity and Waist Circumference among US adults. Prev. Chronic Dis. 16, E02 (2019).30605422
8. Green, M., Arora, K. & Prakash, S. Microbial medicine: Prebiotic and probiotic functional foods to target obesity and metabolic syndrome. Int. J. Mol. Sci. 21(8), 2890 (2020).
9. Backhed F Ley RE Sonnenburg JL Peterson DA Gordon JI Host-bacterial mutualism in the human intestine Science 2005 307 5717 1915 1920 10.1126/science.1104816 15790844
Backhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. & Gordon, J. I. Host-bacterial mutualism in the human intestine. Science. 307(5717), 1915–1920 (2005).15790844
10. Chen Y Zhou J Wang L Role and mechanism of Gut Microbiota in Human Disease Front. Cell. Infect. Microbiol. 2021 11 625913 10.3389/fcimb.2021.625913 33816335
Chen, Y., Zhou, J. & Wang, L. Role and mechanism of Gut Microbiota in Human Disease. Front. Cell. Infect. Microbiol. 11, 625913 (2021).33816335
11. Adak A Khan MR An insight into gut microbiota and its functionalities Cell. Mol. Life Sci. 2019 76 3 473 493 10.1007/s00018-018-2943-4 30317530
Adak, A. & Khan, M. R. An insight into gut microbiota and its functionalities. Cell. Mol. Life Sci. 76(3), 473–493 (2019).30317530
12. Bell DS Changes seen in gut bacteria content and distribution with obesity: Causation or association? Postgrad. Med. 2015 127 8 863 868 10.1080/00325481.2015.1098519 26474235
Bell, D. S. Changes seen in gut bacteria content and distribution with obesity: Causation or association? Postgrad. Med. 127(8), 863–868 (2015).26474235
13. Ley RE Obesity alters gut microbial ecology Proc. Natl. Acad. Sci. U S A 2005 102 31 11070 11075 10.1073/pnas.0504978102 16033867
Ley, R. E. et al. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U S A. 102(31), 11070–11075 (2005).16033867
14. Cani PD Osto M Geurts L Everard A Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity Gut Microbes 2012 3 4 279 288 10.4161/gmic.19625 22572877
Cani, P. D., Osto, M., Geurts, L. & Everard, A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 3(4), 279–288 (2012).22572877
15. Dahiya DK Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: A review Front. Microbiol. 2017 8 563 10.3389/fmicb.2017.00563 28421057
Dahiya, D. K. et al. Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: A review. Front. Microbiol. 8, 563 (2017).28421057
16. Kobyliak N Probiotics in prevention and treatment of obesity: A critical view Nutr. Metab. (Lond) 2016 13 14 10.1186/s12986-016-0067-0 26900391
Kobyliak, N. et al. Probiotics in prevention and treatment of obesity: A critical view. Nutr. Metab. (Lond). 13, 14 (2016).26900391
17. Hill C Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic Nat. Rev. Gastroenterol. Hepatol. 2014 11 8 506 514 10.1038/nrgastro.2014.66 24912386
Hill, C. et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11(8), 506–514 (2014).24912386
18. Cooper TE Synbiotics, prebiotics and probiotics for people with chronic kidney disease Cochrane Database Syst. Rev. 2023 10 10 CD013631 37870148
Cooper, T. E. et al. Synbiotics, prebiotics and probiotics for people with chronic kidney disease. Cochrane Database Syst. Rev. 10(10), CD013631 (2023).37870148
19. Roshanravan N A comprehensive systematic review of the effectiveness of Akkermansia muciniphila, a member of the gut microbiome, for the management of obesity and associated metabolic disorders Arch. Physiol. Biochem. 2023 129 3 741 751 10.1080/13813455.2021.1871760 33449810
Roshanravan, N. et al. A comprehensive systematic review of the effectiveness of Akkermansia muciniphila, a member of the gut microbiome, for the management of obesity and associated metabolic disorders. Arch. Physiol. Biochem. 129(3), 741–751 (2023).33449810
20. Quigley EMM Prebiotics and Probiotics in Digestive Health Clin. Gastroenterol. Hepatol. 2019 17 2 333 344 10.1016/j.cgh.2018.09.028 30267869
Quigley, E. M. M. Prebiotics and Probiotics in Digestive Health. Clin. Gastroenterol. Hepatol. 17(2), 333–344 (2019).30267869
21. Gu W Association of rest-activity circadian rhythm with chronic respiratory diseases, a cross-section survey from NHANES 2011–2014 Respir Med. 2023 209 107147 10.1016/j.rmed.2023.107147 36754218
Gu, W. et al. Association of rest-activity circadian rhythm with chronic respiratory diseases, a cross-section survey from NHANES 2011–2014. Respir Med. 209, 107147 (2023).36754218
22. Huo X Association of dietary live microbe intake with abdominal aortic calcification in US adults: A cross-sectional study of NHANES 2013–2014 Front. Nutr. 2023 10 1267607 10.3389/fnut.2023.1267607 38075227
Huo, X. et al. Association of dietary live microbe intake with abdominal aortic calcification in US adults: A cross-sectional study of NHANES 2013–2014. Front. Nutr. 10, 1267607 (2023).38075227
23. Wang X High dietary live microbe intake is correlated with reduced risk of depressive symptoms: A cross-sectional study of NHANES 2007–2016 J. Affect. Disord 2024 344 198 206 10.1016/j.jad.2023.10.015 37827261
Wang, X. et al. High dietary live microbe intake is correlated with reduced risk of depressive symptoms: A cross-sectional study of NHANES 2007–2016. J. Affect. Disord. 344, 198–206 (2024).37827261
24. Marco ML A classification system for defining and estimating Dietary Intake of Live microbes in US adults and children J. Nutr. 2022 152 7 1729 1736 10.1093/jn/nxac074 35583208
Marco, M. L. et al. A classification system for defining and estimating Dietary Intake of Live microbes in US adults and children. J. Nutr. 152(7), 1729–1736 (2022).35583208
25. American College of Cardiology/American Heart Association Task Force on PracticeGuidelines OEP Executive summary: Guidelines (2013) for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society published by the Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Based on a systematic review from the the obesity Expert Panel, 2013 Obes. (Silver Spring) 2014 22 Suppl 2 S5 39
American College of Cardiology/American Heart Association Task Force on Practice & Guidelines, O. E. P. Executive summary: Guidelines (2013) for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society published by the Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Based on a systematic review from the the obesity Expert Panel, 2013. Obes. (Silver Spring). 22(Suppl 2), S5–39 (2014).
26. Expert Panel on Detection E Treatment of high blood cholesterol in A: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 2001 285 19 2486 2497 10.1001/jama.285.19.2486 11368702
Expert Panel on Detection E. Treatment of high blood cholesterol in A: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 285(19), 2486–2497 (2001).11368702
27. Wang L Yi Z Marital status and all-cause mortality rate in older adults: A population-based prospective cohort study BMC Geriatr. 2023 23 1 214 10.1186/s12877-023-03880-8 37016371
Wang, L. & Yi, Z. Marital status and all-cause mortality rate in older adults: A population-based prospective cohort study. BMC Geriatr. 23(1), 214 (2023).37016371
28. Fadeyev, K., Nagao-Sato, S. & Reicks, M. Nutrient and Food Group Intakes among U.S. Children (2–5 Years) Differ by Family Income to Poverty Ratio, NHANES 2011–2018. Int J Environ Res Public Health 18(22). (2021).
29. Qiu Z Associations of serum carotenoids with risk of Cardiovascular Mortality among individuals with type 2 diabetes: Results from NHANES Diabetes Care 2022 45 6 1453 1461 10.2337/dc21-2371 35503926
Qiu, Z. et al. Associations of serum carotenoids with risk of Cardiovascular Mortality among individuals with type 2 diabetes: Results from NHANES. Diabetes Care. 45(6), 1453–1461 (2022).35503926
30. Liang J Association between Joint Physical Activity and Dietary Quality and Lower Risk of Depression symptoms in US Adults: Cross-sectional NHANES Study JMIR Public. Health Surveill 2023 9 e45776 10.2196/45776 37163324
Liang, J. et al. Association between Joint Physical Activity and Dietary Quality and Lower Risk of Depression symptoms in US Adults: Cross-sectional NHANES Study. JMIR Public. Health Surveill. 9, e45776 (2023).37163324
31. Collaboration NCDRF Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants Lancet 2016 387 10026 1377 1396 10.1016/S0140-6736(16)30054-X 27115820
Collaboration, N. C. D. R. F. Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 387(10026), 1377–1396 (2016).27115820
32. Conway B Rene A Obesity as a disease: No lightweight matter Obes. Rev. 2004 5 3 145 151 10.1111/j.1467-789X.2004.00144.x 15245383
Conway, B. & Rene, A. Obesity as a disease: No lightweight matter. Obes. Rev. 5(3), 145–151 (2004).15245383
33. Mohammed MS Sendra S Lloret J Bosch I Systems and WBANs for Controlling obesity J. Healthc. Eng. 2018 2018 1564748 10.1155/2018/1564748 29599941
Mohammed, M. S., Sendra, S., Lloret, J. & Bosch, I. Systems and WBANs for Controlling obesity. J. Healthc. Eng. 2018, 1564748 (2018).29599941
34. Castaner O The gut Microbiome Profile in obesity: A systematic review Int. J. Endocrinol. 2018 2018 4095789 29849617
Castaner, O. et al. The gut Microbiome Profile in obesity: A systematic review. Int. J. Endocrinol. 2018, 4095789 (2018).29849617
35. Turnbaugh PJ An obesity-associated gut microbiome with increased capacity for energy harvest Nature 2006 444 7122 1027 1031 10.1038/nature05414 17183312
Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444(7122), 1027–1031 (2006).17183312
36. Kim J Yun JM Kim MK Kwon O Cho B Lactobacillus gasseri BNR17 supplementation reduces the visceral Fat Accumulation and Waist circumference in obese adults: A Randomized, Double-Blind, placebo-controlled trial J. Med. Food 2018 21 5 454 461 10.1089/jmf.2017.3937 29688793
Kim, J., Yun, J. M., Kim, M. K., Kwon, O. & Cho, B. Lactobacillus gasseri BNR17 supplementation reduces the visceral Fat Accumulation and Waist circumference in obese adults: A Randomized, Double-Blind, placebo-controlled trial. J. Med. Food. 21(5), 454–461 (2018).29688793
37. Hadi A Sepandi M Marx W Moradi S Parastouei K Clinical and psychological responses to synbiotic supplementation in obese or overweight adults: A randomized clinical trial Complement. Ther. Med. 2019 47 102216 10.1016/j.ctim.2019.102216 31780038
Hadi, A., Sepandi, M., Marx, W., Moradi, S. & Parastouei, K. Clinical and psychological responses to synbiotic supplementation in obese or overweight adults: A randomized clinical trial. Complement. Ther. Med. 47, 102216 (2019).31780038
38. Kadooka Y Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial Eur. J. Clin. Nutr. 2010 64 6 636 643 10.1038/ejcn.2010.19 20216555
Kadooka, Y. et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur. J. Clin. Nutr. 64(6), 636–643 (2010).20216555
39. Sharafedtinov KK Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients–a randomized double-blind placebo-controlled pilot study Nutr. J. 2013 12 138 10.1186/1475-2891-12-138 24120179
Sharafedtinov, K. K. et al. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients–a randomized double-blind placebo-controlled pilot study. Nutr. J. 12, 138 (2013).24120179
40. Mohammadi-Sartang M The effect of daily fortified yogurt consumption on weight loss in adults with metabolic syndrome: A 10-week randomized controlled trial Nutr. Metab. Cardiovasc. Dis. 2018 28 6 565 574 10.1016/j.numecd.2018.03.001 29724529
Mohammadi-Sartang, M. et al. The effect of daily fortified yogurt consumption on weight loss in adults with metabolic syndrome: A 10-week randomized controlled trial. Nutr. Metab. Cardiovasc. Dis. 28(6), 565–574 (2018).29724529
41. Flach J van der Waal MB van den Nieuwboer M Claassen E Larsen OFA The underexposed role of food matrices in probiotic products: Reviewing the relationship between carrier matrices and product parameters Crit. Rev. Food Sci. Nutr. 2018 58 15 2570 2584 10.1080/10408398.2017.1334624 28609116
Flach, J., van der Waal, M. B., van den Nieuwboer, M., Claassen, E. & Larsen, O. F. A. The underexposed role of food matrices in probiotic products: Reviewing the relationship between carrier matrices and product parameters. Crit. Rev. Food Sci. Nutr. 58(15), 2570–2584 (2018).28609116
42. Gomes AC The additional effects of a probiotic mix on abdominal adiposity and antioxidant status: A double-blind, randomized trial Obes. (Silver Spring) 2017 25 1 30 38 10.1002/oby.21671
Gomes, A. C. et al. The additional effects of a probiotic mix on abdominal adiposity and antioxidant status: A double-blind, randomized trial. Obes. (Silver Spring). 25(1), 30–38 (2017).
43. Markowiak, P. & Slizewska, K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 9(9), 1021 (2017).
44. Quigley EMM Nutraceuticals as modulators of gut microbiota: Role in therapy Br. J. Pharmacol. 2020 177 6 1351 1362 10.1111/bph.14902 31659751
Quigley, E. M. M. Nutraceuticals as modulators of gut microbiota: Role in therapy. Br. J. Pharmacol. 177(6), 1351–1362 (2020).31659751
45. Sanmiguel C Gupta A Mayer EA Gut microbiome and obesity: A plausible explanation for obesity Curr. Obes. Rep. 2015 4 2 250 261 10.1007/s13679-015-0152-0 26029487
Sanmiguel, C., Gupta, A. & Mayer, E. A. Gut microbiome and obesity: A plausible explanation for obesity. Curr. Obes. Rep. 4(2), 250–261 (2015).26029487
46. Geurts L Neyrinck AM Delzenne NM Knauf C Cani PD Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: Novel insights into molecular targets and interventions using prebiotics Benef Microbes 2014 5 1 3 17 10.3920/BM2012.0065 23886976
Geurts, L., Neyrinck, A. M., Delzenne, N. M., Knauf, C. & Cani, P. D. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: Novel insights into molecular targets and interventions using prebiotics. Benef Microbes. 5(1), 3–17 (2014).23886976
47. Roselli M Impact of supplementation with a food-derived microbial community on obesity-associated inflammation and gut microbiota composition Genes Nutr. 2017 12 25 10.1186/s12263-017-0583-1 29043005
Roselli, M. et al. Impact of supplementation with a food-derived microbial community on obesity-associated inflammation and gut microbiota composition. Genes Nutr. 12, 25 (2017).29043005
48. Plaza-Diaz J Ruiz-Ojeda FJ Gil-Campos M Gil A Mechanisms of action of Probiotics Adv. Nutr. 2019 10 suppl_1 S49 S66 10.1093/advances/nmy063 30721959
Plaza-Diaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M. & Gil, A. Mechanisms of action of Probiotics. Adv. Nutr. 10(suppl_1), S49–S66 (2019).30721959
49. Kang Y Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability Pharmacol. Res. 2022 175 106020 10.1016/j.phrs.2021.106020 34896249
Kang, Y. et al. Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability. Pharmacol. Res. 175, 106020 (2022).34896249
